It may start with something completely ordinary.

A surgery.

A serious injury.

A painful medical condition.

A prescription is written for an opioid because the patient is hurting.

The patient takes the medication because their doctor prescribed it.

And it helps.

For many people, that is where the story ends. The pain improves, the medication is stopped, and life moves forward.

But for some patients, the story becomes more complicated.

The medication continues.

The body adapts.

The original prescription gets renewed.

Pain persists.

Stopping becomes difficult.

And somewhere along the way, a patient who entered healthcare because they were in pain may find themselves dealing with something they never expected.

Dependence.

Or, for some people, opioid use disorder.

Understanding how that can happen matters.

Because not every person struggling with an opioid started by looking for drugs.

Some started with a prescription.

A Prescription Does Not Make a Medication Risk-Free

Prescription opioids can be appropriate and valuable medications.

They can provide important pain relief after major surgery, serious injury, cancer, and in other circumstances where their benefits may outweigh their risks.

But being prescribed by a healthcare professional does not remove the risks associated with them.

Opioids can cause sedation, constipation, respiratory depression, tolerance, physical dependence, and overdose.

Some people can also develop opioid use disorder.

That doesn’t mean everyone who receives an opioid will become addicted.

Most will not.

But it does mean prescribing should come with more than instructions printed on a bottle.

It should come with a plan.

Tolerance, Dependence, and Addiction Are Not the Same Thing

These words are often used interchangeably.

They shouldn’t be.

Tolerance means the body has adapted to a medication so that its effects may change over time. A person may need a different dose to achieve an effect that previously occurred at a lower dose.

Physical dependence means the body has adapted to the presence of the medication. If it is stopped abruptly, withdrawal symptoms can occur.

Physical dependence can develop during appropriate medical treatment.

It does not automatically mean someone is addicted.

Opioid use disorder is different.

It involves a problematic pattern of opioid use that leads to significant impairment or distress. It may involve difficulty controlling use, continued use despite harm, cravings, or other behaviors and consequences.

A person can be physically dependent without having opioid use disorder.

And a person with opioid use disorder deserves treatment—not judgment.

Those distinctions matter because labeling every physically dependent patient as an “addict” is inaccurate.

But ignoring the possibility that opioid use can become problematic is dangerous too.

Sometimes the Medication Outlasts the Original Problem

Imagine being discharged after surgery with an opioid prescription.

The first week, you clearly need it.

The second week, you’re still hurting.

Maybe another prescription is provided.

Then another.

Perhaps the pain hasn’t resolved as expected.

Perhaps no one has really talked with you about when or how the medication should be reduced.

Perhaps you’re seeing several healthcare professionals, and everyone assumes someone else is managing the bigger picture.

Months later, the situation may look very different from the one that existed when the medication was first prescribed.

That doesn’t mean someone necessarily did something wrong.

But it does demonstrate why follow-up matters.

The question shouldn’t only be:

“Does the patient still have pain?”

It should also be:

“Is this medication still helping enough to justify its risks?”

The Opioid Crisis Did Not Begin With Patients Alone

It is impossible to talk about prescription opioid problems honestly without acknowledging the history of opioid prescribing in the United States.

During the 1990s and 2000s, opioid prescribing increased substantially.

Some pharmaceutical companies aggressively promoted opioid medications while minimizing or misrepresenting their risks. OxyContin, manufactured by Purdue Pharma, became one of the best-known examples and eventually became central to litigation, government investigations, and the broader reckoning over prescription opioid marketing.

Healthcare prescribing practices were part of that history too.

Many clinicians were encouraged to treat pain more aggressively, and opioids were prescribed widely.

The consequences became devastating.

But history matters for another reason.

It reminds us that the opioid crisis cannot be explained simply by saying:

“People became drug-seekers.”

Patients were prescribed these medications within a healthcare system.

Some developed problems while taking medications that had originally been provided for legitimate medical reasons.

That history deserves to remain part of the conversation.

Prescribing Should Include Follow-Up

Starting an opioid should not mean:

Here’s the prescription. Good luck.

Depending on the situation, follow-up may include asking:

Is the pain improving?

Is the medication helping the patient function?

How often is the patient actually taking it?

Are side effects developing?

Is the dose increasing?

Are other medications or substances creating additional risk?

Is the opioid still necessary?

Can the dose be reduced?

Would other pain treatments help?

Is there evidence that the patient’s relationship with the medication is changing?

Those conversations aren’t accusations.

They are part of safe medication management.

Stopping Can Be More Complicated Than Starting

A patient who has taken an opioid regularly for a prolonged period may develop physical dependence.

That means suddenly stopping the medication can cause withdrawal.

Symptoms can include anxiety, sweating, nausea, diarrhea, muscle aches, restlessness, difficulty sleeping, and other uncomfortable symptoms.

That is one reason long-term opioid therapy shouldn’t generally be abruptly discontinued without considering the individual patient’s circumstances.

A taper may be appropriate for some patients.

Others may need a different approach.

And patients who have developed opioid use disorder may benefit from evidence-based treatment specifically designed for that condition.

The answer isn’t simply:

“You shouldn’t be taking this anymore.”

The question becomes:

“What is the safest way forward from where you are now?”

When the Patient Realizes Something Has Changed

Sometimes the patient notices before anyone else.

You may begin worrying about when the next dose is due.

You may find yourself taking medication differently than intended.

You may feel sick when you miss a dose.

You may be running out earlier than expected.

You may find yourself thinking about the medication far more than you used to.

Or perhaps you simply realize:

I don’t know how to stop taking this.

That is something to talk about.

It does not mean you need to diagnose yourself.

And it does not mean you deserve to be punished or dismissed.

It means the medication deserves reassessment.

Asking for Help Should Not Become Evidence Against You

This is where healthcare can unintentionally create a terrible contradiction.

We tell patients to speak up when something is wrong.

Then a patient says:

“I’m worried I’ve become dependent on this medication.”

Or:

“I think I’m losing control of this.”

And they may fear that the admission will follow them forever.

That fear can keep people silent.

Patients need to know that opioid use disorder is a treatable medical condition.

Treatment may include medications such as buprenorphine or methadone along with other medical, psychological, and social support depending on the person’s needs.

Seeking help should be the beginning of treatment.

Not the end of compassion.

Healthcare Has Responsibilities on Both Sides of the Prescription

Patients have responsibilities when taking controlled medications.

Take medications as directed.

Store them safely.

Don’t share them.

Talk openly about other medications and substances being used.

Report side effects and concerns.

Ask questions when something doesn’t make sense.

But healthcare has responsibilities too.

Prescribe thoughtfully.

Explain risks.

Reassess.

Monitor.

Talk about the plan for continuing or stopping treatment.

Recognize when the situation is changing.

And help the patient navigate what comes next.

Responsibility should not disappear once the prescription leaves the pharmacy.

We Can Hold Two Truths at the Same Time

Opioids can relieve suffering.

Opioids can also cause serious harm.

Some people need them.

Some people are harmed by them.

Physical dependence is not automatically addiction.

Opioid use disorder is real.

Safe prescribing matters.

So does compassionate pain treatment.

None of those truths cancel the others.

The opioid crisis taught healthcare painful lessons about prescribing.

But one of those lessons should not be that every patient who needs pain medication deserves suspicion.

And another should not be that someone who develops a problem with a medication they were originally prescribed deserves abandonment.

Sometimes the most important question isn’t:

“Why did this patient let this happen?”

It is:

“How did we get here, and what does this patient need now?”

Because when healthcare participates in starting a medication, healthcare should also be willing to help when the relationship with that medication becomes complicated.

References

Centers for Disease Control and Prevention. CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022.

National Institute on Drug Abuse. Prescription Opioids DrugFacts.

Substance Abuse and Mental Health Services Administration. Medications for Substance Use Disorders.

U.S. Food and Drug Administration. FDA Identifies Harm Reported From Sudden Discontinuation of Opioid Pain Medicines and Requires Label Changes to Guide Prescribers on Gradual, Individualized Tapering.

U.S. Department of Justice. Purdue Pharma Pleads Guilty to Felonies Related to Opioid Marketing and Distribution.